Can blood tranfusion transmit cancer? A literature review

Transfusion Medicine Reviews
Hung YangAnthony J Keller

Abstract

Blood services around the world face increasing challenges in recruiting voluntary blood donors. With increasing donor restrictions and ageing populations, it is essential to look for any existing restrictions that may be relaxed in the light of currently available evidence. We propose that one such restriction is the exclusion of blood donors with a history of a malignancy. Most blood services apart from the United States and Australia continue the historical precaution of permanently excluding donors with a history of cancer, despite the absence of any convincing reports of cancer transmission among the millions of allogeneic blood transfusions performed since the advent of blood banking. In 2007, workers in Scandinavia published convincing data from the SCANDAT (Scandinavian Donations and Transfusions) database that showed no increase in cancer risk among recipients of blood from "precancerous" donors (ie, donors who were later diagnosed with cancer within 5 years of donating) vs recipients of blood from other donors. This review aims to reconcile this finding with other data available in the published literature that is pertinent to the risk of transmitting cancer via blood transfusion, with a view to establishing that ther...Continue Reading

References

Jul 1, 1985·British Journal of Haematology·J L SmithA J Provisor
Aug 1, 1994·International Journal of Cancer. Journal International Du Cancer·A Memon, R Doll
Jul 1, 1993·Annals of Internal Medicine·J R CerhanR J Prineas
Nov 14, 1996·The New England Journal of Medicine·H V GärtnerB Bültmann
May 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·E RacilaJ W Uhr
Sep 30, 1999·Transfusion·W H Dzik, A Okayama
Jan 17, 2002·The New England Journal of Medicine·K D BergJ R Eshleman
Mar 13, 2002·Transplantation·H Myron KauffmanFrancis L Delmonico
Aug 29, 2003·The New England Journal of Medicine·Frederic BaronYves Beguin
Nov 25, 2003·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Sandy FengDouglas W Hanto
Dec 9, 2004·Transfusion·Jonathan H Waters
Apr 26, 2006·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Olga Sala-TorraJerald P Radich
Aug 22, 2006·Journal of Hepatology·Joseph F BuellE Steve Woodle
Apr 19, 2007·Cell and Tissue Banking·Manish J Gandhi, D Michael Strong
Apr 26, 2007·Vox Sanguinis·M GoldmanT Steed
Dec 13, 2007·Journal of the National Cancer Institute·Henrik HjalgrimMads Melbye
Jul 22, 2008·The Lancet Oncology·Michel P ColemanUNKNOWN CONCORD Working Group
Aug 30, 2008·Pathology·UNKNOWN Royal College of Pathologists of Australasia, UNKNOWN Australasian Association of Clinical Biochemists

❮ Previous
Next ❯

Citations

Jul 2, 2011·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·G CanelliniJ-D Tissot

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Basal Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.